Inactive Instrument
Bioasis Technologies Inc. Stock Toronto S.E.
Stocks
BTI.H
CA09064N1033
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 1.56M 1.11M 970K 895K 825K 107M 1.59M 10.7M 4.2M 52.33M 4.17M 4.08M 180M | P/E 2021 |
37.2x | P/E 2022 | -6.45x |
|---|---|---|---|---|---|
| Enterprise Value | 1.73M 1.23M 1.08M 993K 916K 119M 1.77M 11.88M 4.66M 58.08M 4.63M 4.52M 200M | EV / Sales 2021 |
6.07x | EV / Sales 2022 | 516x |
| Free-Float |
97.95% | Yield 2021 * |
-
| Yield 2022 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Deborah Rathjen
CEO | Chief Executive Officer | - | 2019-03-10 |
Dave Jenkins
DFI | Director of Finance/CFO | - | 2021-06-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 7.94K | |
| -1.29% | -2.54% | -0.35% | +4.30% | 49.7B | |
| +3.90% | -2.60% | +384.79% | +598.27% | 38.09B | |
| -1.70% | +3.03% | +11.77% | +58.93% | 35.29B | |
| -2.01% | -1.30% | +30.02% | -6.71% | 35.13B | |
| +0.06% | +1.56% | +4.41% | +27.42% | 27.22B | |
| +0.46% | -5.24% | - | - | 16.14B | |
| -0.04% | +0.42% | +70.80% | +121.10% | 15.36B | |
| +1.12% | +2.15% | +16.24% | +19.12% | 13.89B | |
| 0.00% | +0.73% | +18.02% | -30.96% | 13.02B | |
| Average | +0.05% | -0.57% | +66.96% | +98.93% | 27.09B | |
| Weighted average by Cap. | -0.09% | -0.64% | +78.08% | +119.96% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 4.08M 2.91M 2.54M 2.35M 2.16M 280M 4.17M 28.04M 11M 137M 10.93M 10.68M 472M | 37.72K 26.89K 23.53K 21.69K 20K 2.59M 38.57K 259K 102K 1.27M 101K 98.84K 4.37M |
| Net income | 698K 498K 436K 402K 370K 47.95M 714K 4.8M 1.88M 23.49M 1.87M 1.83M 80.87M | -2.96M -2.11M -1.85M -1.7M -1.57M -203M -3.03M -20.36M -7.99M -99.55M -7.93M -7.76M -343M |
| Net Debt | -2.62M -1.87M -1.64M -1.51M -1.39M -180M -2.68M -18.04M -7.08M -88.22M -7.03M -6.87M -304M | 171K 122K 107K 98.33K 90.66K 11.74M 175K 1.18M 461K 5.75M 458K 448K 19.8M |
Employees
-
Choose MarketScreener 
